首页 > 市场调查报告书 > 医疗设备

手术用器具

市场调查报告书

商品编码

1374796

全球胸腔引流装置市场-2023-2030

Global Thoracic Drainage Devices Market -2023-2030

出版日期: 2023年11月01日 | 出版商:

DataM Intelligence | 英文 186 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

概述

由于患者对微创技术的偏好而转向微创胸腔引流手术等趋势预计将主导全球胸腔引流设备市场。

近年来，全球胸腔引流装置市场显着成长，预计将持续维持上升趋势。市场正在经历一个转型期，受到几个重要趋势的影响，例如配备连接功能的胸腔引流系统数位化，允许即时监控患者、远端资料存取和改进患者管理。

此外，胸部疾病盛行率不断上升，胸腔引流装置技术的不断进步，提高了其效率和安全性，且胸腔手术（包括肺切除和移植）的数量不断增加，需要胸腔引流装置进行术后护理，从而推动了胸腔引流装置的使用。排水设备市场规模。新技术研究活动的不断增长以及製药医疗技术公司的存在是北美地区需求的一些因素。 ATMOS MedizinTechnik GmbH & Co. K、Becton、Dickinson and Company 等重要竞争对手以及其他在市场上积极运作的公司。

动力学

胸腔手术数量的增加推动胸腔引流装置市场的成长

胸腔手术数量的增加是推动胸腔引流装置市场的重要因素。这些装置在心胸外科手术中至关重要，因为它们可以从心包膜和胸膜腔中排出血液、液体和空气，减少术后问题，并最大限度地减少积液、填塞、气胸和出血等问题。在改进的数位引流设备开发之前，经典的三腔吸引技术是过去五年胸腔外科的标准。

例如，根据美国国家医学图书馆2022 年发表的一篇文章，光是在美国，每年就有约53 万例普通胸腔外科手术由约4,000 名心胸外科医师进行，其中大多数是男性（92%），平均年龄56岁。胸腔外科医师平均每年为 135 名患者进行手术。胸部手术的增加强调了市场在改善患者护理和治疗效果方面的成长潜力。

技术进步将推动胸腔引流装置市场成长

包括先进设计的胸腔引流装置的不断进步预计将推动市场的发展。例如，2023 年 9 月，Merit Medical Systems, Inc. 宣布推出 Aspira 真空引流瓶。 Aspira 引流系统用于治疗復发性和有症状的胸腔积液（肺外液体积聚）和恶性腹水（癌症引起的腹部液体积聚）。

此外，Aspira 引流系统用于引流经常需要院内引流的复发性胸腔积液和恶性腹水的适应症显示了尖端引流技术在改善病患照护和生活品质方面的关键作用。因此，随着越来越多的医疗机构和专业人员采用尖端解决方案，在预测期内提高效率、精度和患者治疗效果的技术改进的推动下，胸腔引流设备市场预计将增长。

缺乏熟练的专业人员将阻碍市场的成长

缺乏熟练的专业人员是这个市场的主要限制。胸腔引流是一种先进的外科手术，需要跨学科协作，护理师在胸管插入和护理中发挥重要作用。然而，住院医师插入的胸管经常会出现问题，强调需要进一步训练。

此外，胸管插入是放射科医师、肺科专家和胸腔外科医师执行的常见手术。根据北美放射学会2022年的文章，英国放射科医生短缺，因为欧洲每10万人就有13名放射科医生，但英国的比例仅为每10万人8.5名。因此，由于这一因素，预计市场将在预测期内增长。

The global thoracic drainage devices market has grown significantly in recent years and is projected to continue on its upward trend. The market is undergoing a transformational period, influenced by several significant trends such as digitalization in chest drainage systems equipped with connectivity features allowing real-time monitoring of patients, remote data access, and improved patient management.

Furthermore, the rising prevalence of thoracic diseases, Continuous technological advancements in thoracic drainage devices have improved their efficiency and safety and increasing number of thoracic surgeries, including lung resections and transplantations, that requires thoracic drainage devices for post-operative care are driving up the thoracic drainage devices market size. The growing research activities for new technologies and presence of establish pharmaceutical medtech companies are some of the factors in demand from North American regions. With significant competitors like ATMOS MedizinTechnik GmbH & Co. K, Becton, Dickinson and Company, and others actively operating in the market.

Dynamics

The Increasing Number of Thoracic Surgeries to Drive the Growth of the Thoracic Drainage Devices Market

The increasing number of thoracic surgeries is an important factor driving in the market for thoracic drainage devices. These devices are essential in cardiothoracic surgery because they allow for the drainage of blood, fluids, and air from the pericardial and pleural cavities, reducing post-operative problems and minimizing concerns such as effusions, tamponade, pneumothoraces, and hemorrhage. Prior to the development of improved digital drainage devices, the classic 3-chamber suction technique was the standard in thoracic surgery for the past five decades.

For instance, according to a National Library of Medicine article published in 2022, states that about 530,000 general thoracic surgery cases are performed annually in the U.S alone by approximately 4,000 cardiothoracic surgeons, the majority of them are male (92%), with an average age of 56 years. The average thoracic surgeon performs 135 patients per year. This increase in thoracic procedures emphasizes the market's potential for growth in enhancing patient care and outcomes.

The Advancements in Technologies will Drive the Thoracic Drainage Devices Market Growth

The growing advancements in thoracic drainage devices emcompassing advanced design is expected to drive the market. For instance, in September 2023, Merit Medical Systems, Inc. announced the launch of its Aspira Evacuated Drainage Bottle. The Aspira Drainage System is used to treat recurring and symptomatic pleural effusions (fluid buildup outside the lungs) and malignant ascites (fluid buildup in the abdomen caused by cancer).

Furthermore, the indications for the Aspira Drainage System for draining recurrent pleural effusions and malignant ascites, both of which frequently require in-hospital drainage, show the crucial role of cutting-edge drainage technologies in improving patient care and quality of life. Thus, as more healthcare organizations and professionals adopt cutting-edge solutions, the market for thoracic drainage devices is expected to grow, fueled by technological improvements that improve efficiency, precision, and patient outcomes over the forecast period.

The Lack of Availability of Skilled Professional Will Hamper the Growth of the Market

The lack of availability of skilled professional is the major restraint for this market. Thoracic drainage is an advanced surgical procedure that requires interdisciplinary collaboration, and nurses play a significant role in chest tube insertion and care. However, chest tubes inserted by resident physicians are frequently associated with problems, emphasizing the need for further training.

Furthermore, chest tube insertion is a common procedure performed by radiologists, pulmonary specialists, and thoracic surgeons. According to the Radiological Society of North America 2022 article, there is a shortage of radiologists in the U.K, since Europe has 13 radiologists per 100,000 people, but the rate in the U.K. is only 8.5 per 100,000. Thus, owing to this factor the market is expected to grow over the forecast period.

Segment Analysis

The global thoracic drainage devices market is segmented based on product, material type, application, end user and region.

Owing to the Better Effectiveness and Variety, the Chest Drainage Systems Segment Accounted for Approximately 47.2% of the Thoracic Drainage Devices Market Share

The chest drainage systems segment is expected to dominate the thoracic drainage device market. These systems are widely used in a variety of clinical settings, including cardiac surgery, cardiothoracic surgery, pulmonology, and critical care, to treat diseases such as pleural effusion, pneumothorax, hemothorax, and post-operative drainage.

This segment's is dominated due to the variety and effectiveness of chest drainage devices in removing air and fluids from the pleural area, hence aiding lung re-expansion and reducing problems. Furthermore, contemporary technological advancements in digital chest drainage systems, which allow for real-time monitoring and enhanced patient management, contribute to their widespread acceptability.

For instance, in July 2022, Centese, Inc. announced the first peer-reviewed study for its Thoraguard digital drainage system for cardiac surgery at Stanford University Medical Center, which was published in the Journal of Thoracic and Cardiovascular Surgery Open. Thoraguard is the first and only digital chest tube management system that delivers automated clog removal without human intervention while continuously and precisely monitoring vital physiological indicators to support clinical decision-making and enhance outcomes. Furthermore, when utilized during heart surgery, Thoraguard was demonstrated to be safe and efficacious when compared to standard analog chest tubes. Thus, owing to the above factors the segment is expected to dominate over the forecast period.

Geographical Penetration

North America Accounted for Approximately 38.2% of the Market Share in 2022, Owing to the Increasing Number of Clinical Trials

The increasing number of clinical trials in North America is expected to dominate the thoracic drainage device market. Clinical trials play a vital role in determining the safety and efficacy of novel devices. For instance, the University of Oklahoma is conducting a clinical trial comparing the Digital Chest Tube Drainage System (Thopaz + ) to the Analog in Pediatric Patients." The purpose of the research is to assess the efficacy of digital (Thopaz + ) and analog (Pleur-evac) drainage devices in pediatric patients. The trial is an interventional, randomized, and controlled study that is expected to enroll 140 people.

Furthermore, the study is expected to be finished by April 1, 2024 and there have been no prospective randomized controlled trials comparing digital versus analog chest tube drainage systems in pediatric patients so far. This will be the first prospective randomized trial to look into the possible benefits of adopting a digital chest tube drainage system in pediatric patients.

Moreover, the increasing prevalence of chronic diseases in North America is also expected to drive the market. Chronic diseases such as heart disease and pulmonology disease are significant drivers of demand for thoracic drainage devices. As the population ages and lifestyle factors increase the prevalence of chronic diseases, the need for appropriate thoracic drainage treatments grows. Thus, owing to the above factors the region is expected to dominate over the forecast period.

Competitive Landscape

The major global players in the thoracic drainage devices market include: ATMOS MedizinTechnik GmbH & Co. K, Becton, Dickinson and Company, Cardinal Health., Cook Group Incorporated, Getinge AB, Sinapi Biomedical, Teleflex Incorporated, Utah Medical Products, Inc., Vygon SA, Sterimed Group, and among others.

COVID-19 Impact Analysis

The World Health Organization (WHO) reported more roughly 585.0 million confirmed COVID-19 cases as of August 2022, with around 6.4 million recorded deaths. However, research has shown that thoracic drainage systems play an important role in preventing the widespread development of COVID-19. Individuals with COVID-19 are at a higher risk of having acute respiratory distress syndrome (ARDS), which requires invasive mechanical ventilation.

Furthermore, COVID-19-related barotrauma frequently results in pneumothorax, necessitating chest tube insertion (thoracostomy). Furthermore, members of the German Health Alliance (GHA), which include prominent companies such as B. Braun, ATMOS MedizinTechnik GmbH & Co. KG, Getinge, and Drager, have seen a significant increase in global demand for their products, particularly thoracic drainage systems, since the beginning of 2020. ATMOS MedizinTechnik GmbH & Co. KG, for example, an innovative medical device maker, has increased production to meet increased demand, realizing that product categories such as drainage systems play a critical role in saving lives in the face of the COVID-19 epidemic.

Key Developments

On April 18, 2022, Merit Medical Systems, Inc., a global leader in the manufacture and marketing of healthcare technologies, stated the launch of the ReSolve Thoracostomy Tray. The new tray includes everything needed to execute a thoracostomy, a minimally invasive method that allows patients to avoid open surgery to drain fluids or air from the chest.
On December 15, 2020, Medela LLC stated that their Thopaz + Digital Chest Drainage and Monitoring System completed various quantitative tests demonstrating that its filtration system efficiently inhibits the passage of aerosolized viral particles such as SARS-CoV-2, the virus responsible for COVID-19.

Why Purchase the Report?

To visualize the global thoracic drainage devices market segmentation based on product, material type, application, end user and region as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of thoracic drainage devices market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping is available in excel consisting of key products of all the major players.

The global thoracic drainage devices market report would provide approximately 53 tables, 54 figures and 195 Pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product
3.2. Snippet by Material Type
3.3. Snippet by Application
3.4. Snippet by End-User
3.5. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. The Increasing Number of Thoracic Surgeries
  - 4.1.1.2. The Advancements in Technologies
- 4.1.2. Restraints
  - 4.1.2.1. The Lack of Availability of Skilled Professional
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's 5 Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID-19
- 6.1.2. Scenario During COVID-19
- 6.1.3. Scenario Post COVID-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. By Product

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 7.1.2. Market Attractiveness Index, By Product
7.2. Chest Drainage Systems*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  - 7.2.2.1. Water Seal Chest Drainage Systems
  - 7.2.2.2. Dry Seal Chest Drainage Systems
  - 7.2.2.3. Digital Chest Drainage Systems
7.3. Thoracic Drainage Kits
7.4. Pleural Drainage Catheters
- 7.4.1. Thoracentesis Catheters
- 7.4.2. Paracentesis Catheters
- 7.4.3. Others
7.5. Trocar Drains
7.6. Others

8. By Material Type

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
- 8.1.2. Market Attractiveness Index, By Material Type
8.2. Silicone*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Polyurethane
8.4. Latex
8.5. Other

9. By Application

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.1.2. Market Attractiveness Index, By Application
9.2. Cardiac Surgery*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Oncology & Pain Management
9.4. Thoracic Surgery & Pulmonology
9.5. General Intensive Care Emergency Medicine
9.6. Others

10. By End-User

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.1.2. Market Attractiveness Index, By End-User
10.2. Hospitals*
- 10.2.1. Introduction
- 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Ambulatory Surgery Centers
10.4. Cardiac Specialty Clinics
10.5. Cardiothoracic Centers
10.6. Others

11. By Region

11.1. Introduction
- 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 11.1.2. Market Attractiveness Index, By Region
11.2. North America
- 11.2.1. Introduction
- 11.2.2. Key Region-Specific Dynamics
- 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
- 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.2.7.1. U.S.
  - 11.2.7.2. Canada
  - 11.2.7.3. Mexico
11.3. Europe
- 11.3.1. Introduction
- 11.3.2. Key Region-Specific Dynamics
- 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
- 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.3.7.1. Germany
  - 11.3.7.2. U.K.
  - 11.3.7.3. France
  - 11.3.7.4. Spain
  - 11.3.7.5. Italy
  - 11.3.7.6. Rest of Europe
11.4. South America
- 11.4.1. Introduction
- 11.4.2. Key Region-Specific Dynamics
- 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
- 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.4.7.1. Brazil
  - 11.4.7.2. Argentina
  - 11.4.7.3. Rest of South America
11.5. Asia-Pacific
- 11.5.1. Introduction
- 11.5.2. Key Region-Specific Dynamics
- 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
- 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.5.7.1. China
  - 11.5.7.2. India
  - 11.5.7.3. Japan
  - 11.5.7.4. Australia
  - 11.5.7.5. Rest of Asia-Pacific
11.6. Middle East and Africa
- 11.6.1. Introduction
- 11.6.2. Key Region-Specific Dynamics
- 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
- 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

12. Competitive Landscape

12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis

13. Company Profiles

13.1. ATMOS MedizinTechnik GmbH & Co. K*
- 13.1.1. Company Overview
- 13.1.2. Product Portfolio and Description
- 13.1.3. Financial Overview
- 13.1.4. Key Developments
13.2. Becton, Dickinson and Company
13.3. Cardinal Health.
13.4. Cook Group Incorporated
13.5. Getinge AB
13.6. Sinapi Biomedical
13.7. Teleflex Incorporated
13.8. Utah Medical Products, Inc.
13.9. Vygon SA
13.10. Sterimed Group

LIST NOT EXHAUSTIVE

14. Appendix

14.1. About Us and Services
14.2. Contact Us

02-2729-4219

+886-2-2729-4219

License/价格

全球胸腔引流装置市场-2023-2030

Global Thoracic Drainage Devices Market -2023-2030

概述

动力学

胸腔手术数量的增加推动胸腔引流装置市场的成长

技术进步将推动胸腔引流装置市场成长

缺乏熟练的专业人员将阻碍市场的成长

目录

第 1 章：方法与范围

第 2 章：定义与概述

第 3 章：执行摘要

第 4 章：动力学

第 5 章：产业分析

第 6 章：COVID-19 分析

第 7 章：副产品

第 8 章：依材料类型

第 9 章：按应用

第 10 章：最终用户

第 11 章：按地区

第 12 章：竞争格局

第 13 章：公司简介

第 14 章：附录

Overview